Skip to main content
. 2021 Jan 30;27(1):87–96. doi: 10.5056/jnm20061

Figure 3.

Figure 3

Summary of the primary endpoint (gastrointestinal symptom [GIS] scores at baseline and week 4 in the per-protocol set population).